BridgeBio Oncology Therapeutics, Inc.
BBOT
$6.76
-$2.11-23.76%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 225.71M | 252.28M | 425.46M | 468.29M | 131.40M |
| Total Receivables | 661.00K | 146.00K | 386.00K | 226.00K | 1.08M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 16.01M | 14.08M | 6.55M | 7.50M | 4.30M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 5.58M |
| Total Current Assets | 242.38M | 266.50M | 432.40M | 476.01M | 142.35M |
|
|
|||||
| Total Current Assets | 242.38M | 266.50M | 432.40M | 476.01M | 142.35M |
| Net Property, Plant & Equipment | 2.98M | 3.16M | 3.29M | 3.27M | 3.45M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 12.93M | 11.37M | 12.70M | 5.52M | 5.46M |
| Total Assets | 376.71M | 417.65M | 448.38M | 484.79M | 151.25M |
|
|
|||||
| Total Accounts Payable | 6.73M | 12.09M | 1.37M | 3.65M | 2.20M |
| Total Accrued Expenses | 43.37M | 29.92M | 32.61M | 30.87M | 24.40M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 554.00K | 538.00K | 522.00K | 506.00K | 320.00K |
| Total Finance Division Other Current Liabilities | 986.00K | 716.00K | 534.00K | 691.00K | 330.00K |
| Total Other Current Liabilities | 986.00K | 716.00K | 534.00K | 691.00K | 330.00K |
| Total Current Liabilities | 51.63M | 43.26M | 35.04M | 35.71M | 27.25M |
|
|
|||||
| Total Current Liabilities | 51.63M | 43.26M | 35.04M | 35.71M | 27.25M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.96M | 2.11M | 2.24M | 2.38M | 2.51M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 53.59M | 45.37M | 37.29M | 38.09M | 29.77M |
|
|
|||||
| Common Stock & APIC | 779.20M | 771.93M | 767.65M | 764.43M | 45.23M |
| Retained Earnings | -455.13M | -398.67M | -356.57M | -317.77M | -273.01M |
| Treasury Stock & Other | -959.00K | -981.00K | 16.00K | 36.00K | 51.00K |
| Total Common Equity | 323.11M | 372.28M | 411.10M | 446.70M | -227.73M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 349.22M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 349.22M |
|
|
|||||
| Total Common Equity | 323.11M | 372.28M | 411.10M | 446.70M | -227.73M |
| Total Preferred Equity | -- | -- | -- | -- | 349.22M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 323.11M | 372.28M | 411.10M | 446.70M | 121.49M |
|
|
|||||